Cargando…
Impairments in Quality of Life and Cognitive Functions in Long-term Survivors of Glioblastoma
BACKGROUND: The incidence of long-term survival in glioblastoma (GBM), i.e., >3 years, ranges from 3% to 5%. Although extensive research is performed in novel therapies for prolonging survival, there is a scarcity of research focusing on the impact of tumor and treatment on cognitive, psychologic...
Autores principales: | Solanki, Chirag, Sadana, Divya, Arimappamagan, Arivazhagan, Rao, K.V.L.N., Rajeswaran, Jamuna, Subbakrishna, D. K., Santosh, Vani, Pandey, Paritosh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402490/ https://www.ncbi.nlm.nih.gov/pubmed/28479798 http://dx.doi.org/10.4103/0976-3147.203829 |
Ejemplares similares
-
miR-219-5p Inhibits Receptor Tyrosine Kinase Pathway by Targeting EGFR in Glioblastoma
por: Rao, Soumya Alige Mahabala, et al.
Publicado: (2013) -
Cbx7 is epigenetically silenced in glioblastoma and inhibits cell migration by targeting YAP/TAZ-dependent transcription
por: Nawaz, Zahid, et al.
Publicado: (2016) -
Impact of somatic copy number alterations on the glioblastoma miRNome: miR‐4484 is a genomically deleted tumour suppressor
por: Nawaz, Zahid, et al.
Publicado: (2017) -
PI3 kinase pathway regulated miRNome in glioblastoma: identification of miR-326 as a tumour suppressor miRNA
por: Nawaz, Zahid, et al.
Publicado: (2016) -
Epigenetically silenced GNG4 inhibits SDF1α/CXCR4 signaling in mesenchymal glioblastoma
por: Pal, Jagriti, et al.
Publicado: (2016)